Ann: Elixinol Global raises A$40m to accelerate international gro, page-38

Hi Stimpsonsocal,

Good to have you on the threads and Elixinol is also available to purchase on the OTC markets as per below

https://www.otcmarkets.com/stock/ELLXF/overview

Just to make it easy Income is called revenue here in Australia and Elixinol reports it’s quarterly revenue of which its last quarter was $8m which grew 119% year on year. The majority of that growth came from its CBD nutraceuticals business based out of Colorado. Their hemp foods business here in Australia accounts for roughly 10% of their business.
Quarterly growth is looking like 20% so I would estimate Revenue of $9.5m for this coming quarter which will be reported in the next couple of weeks.

The 3rd division of their business is the Medical marijuana side which is still waiting for licence approval here in australia.

I hear Elixinol is a top brand in the US and would be great to get some more insight as to where the brand is being distributed and your views on the CBD market and its growth prospects.

On a comparative basis if you compare Elixinol to their competitors CV sciences and Charlottes Web we appear to be very cheap on a multiples calculation, but the market here in australia is not as advanced or aware of how big and fast growing the CBD market is in the US and internationally.

Your insights would be really appreciated.